Fonte: International Journal of Pharmaceutics. Unidade: ICB
Assuntos: FARMACOLOGIA, INIBIDORES DE ENZIMAS, NEOPLASIAS MAMÁRIAS, NANOTECNOLOGIA, ANTINEOPLÁSICOS, FÁRMACOS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PASSOS, Julia Sapienza et al. Contributions of nanotechnology to the intraductal drug delivery for local treatment and prevention of breast cancer. International Journal of Pharmaceutics, v. 635, p. 1-15, 2023Tradução . . Disponível em: https://doi.org/10.1016/j.ijpharm.2023.122681. Acesso em: 21 ago. 2024.APA
Passos, J. S., Dartora, V. F. M. C., Salata, G. C., Malagó, I. D., & Lopes, L. B. (2023). Contributions of nanotechnology to the intraductal drug delivery for local treatment and prevention of breast cancer. International Journal of Pharmaceutics, 635, 1-15. doi:10.1016/j.ijpharm.2023.122681NLM
Passos JS, Dartora VFMC, Salata GC, Malagó ID, Lopes LB. Contributions of nanotechnology to the intraductal drug delivery for local treatment and prevention of breast cancer [Internet]. International Journal of Pharmaceutics. 2023 ; 635 1-15.[citado 2024 ago. 21 ] Available from: https://doi.org/10.1016/j.ijpharm.2023.122681Vancouver
Passos JS, Dartora VFMC, Salata GC, Malagó ID, Lopes LB. Contributions of nanotechnology to the intraductal drug delivery for local treatment and prevention of breast cancer [Internet]. International Journal of Pharmaceutics. 2023 ; 635 1-15.[citado 2024 ago. 21 ] Available from: https://doi.org/10.1016/j.ijpharm.2023.122681